This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.

News

  • 12Jul 2019

    T cell therapy - an personal approach

    Internist-oncologist John Haanen, researcher Wouter Scheper and pharmacist Joost van den Berg of the Netherlands Cancer Institute are going to set up a new T cell therapy in which T cells from the patient are given a helping hand in recognizing the tumor.

    Read More
  • 09Jul 2019

    Marjanka Schmidt appointed professor

    On April 1, 2019, group leader Marjanka Schmidt was appointed endowed professor in Leiden. Her chair at the Leiden University Medical Center is called "Genetic cancer epidemiology, in particular, breast cancer."

    Read More
  • 05Jul 2019

    Solvingt a Molecular Scissors Mystery

    A Netherlands Cancer Institute team, co-led by Thijn Brummelkamp and Anastassis (Tassos) Perrakis, reported independently, but almost simultaneously with three more groups from all over the world, on the crystal structure and mechanism of a peculiar molecular end-tail of the microtubules that constitute the cell skeleton.

    Read More
  • 03Jul 2019

    MRI-movie exposes liver tumor

    An MRI-movie can visualize tumors in the liver prior to irradiation. This was shown by researcher Tessa van de Lindt at the Netherlands Cancer Institute. She developed techniques to capture these moving tumors with MRI. This will save patients an invasive procedure and gives doctors more certainty on the tumor location. She will defend her thesis at the University of Amsterdam on the 5th of July.

    Read More

Board of Directors

Overview boards and commissions

Restaurant.jpg

Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more

Seminar.jpg

Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)

Brochures

Occupation

Total783
Group Leaders51
Postdocs191
PhD Students187
Technicians208
Other146

Facts

  • Silhoutten

    44

    Nationalities

  • Silhoutten

    542

    Publications

  • Horloge

    783

    Employees

  • Silhoutten

    91M

    Project
    Grants

  • Bed

    51

    Research
    Groups

Key Figures Research

Publications in 2016 805
Total impact of publications in 2014 3935
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page